Literature DB >> 33567346

Arbiters of endogenous opioid analgesia: role of CNS estrogenic and glutamatergic systems.

Alan R Gintzler1, Nai-Jiang Liu2.   

Abstract

Nociception and opioid antinociception in females are pliable processes, varying qualitatively and quantitatively over the reproductive cycle. Spinal estrogenic signaling via membrane estrogen receptors (mERs), in combination with multiple other signaling molecules [spinal dynorphin, kappa-opioid receptors (KOR), glutamate and metabotropic glutamate receptor 1 (mGluR1)], appears to function as a master coordinator, parsing functionality between pronociception and antinociception. This provides a window into pharmacologically accessing intrinsic opioid analgesic/anti-allodynic systems. In diestrus, membrane estrogen receptor alpha (mERα) signals via mGluR1 to suppress spinal endomorphin 2 (EM2) analgesia. Strikingly, in the absence of exogenous opioids, interfering with this suppression in a chronic pain model elicits opioid anti-allodynia, revealing contributions of endogenous opioid(s). In proestrus, robust spinal EM2 analgesia is manifest but this requires spinal dynorphin/KOR and glutamate-activated mGluR1. Furthermore, spinal mGluR1 blockade in a proestrus chronic pain animal (eliminating spinal EM2 analgesia) exacerbates mechanical allodynia, revealing tempering by endogenous opioid(s). A complex containing mu-opioid receptor, KOR, aromatase, mGluRs, and mERα are foundational to eliciting endogenous opioid anti-allodynia. Aromatase-mERα oligomers are also plentiful, in a central nervous system region-specific fashion. These can be independently regulated and allow estrogens to act intracellularly within the same signaling complex in which they are synthesized, explaining asynchronous relationships between circulating estrogens and central nervous system estrogen functionalities. Observations with EM2 highlight the translational relevance of extensively characterizing exogenous responsiveness to endogenous opioids and the neuronal circuits that mediate them along with the multiplicity of estrogenic systems that concomitantly function in phase and out-of-phase with the reproductive cycle.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33567346      PMCID: PMC8217383          DOI: 10.1016/j.trsl.2021.02.002

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  108 in total

Review 1.  Sex differences in pain and analgesia: the role of gonadal hormones.

Authors:  Rebecca M Craft; Jeffrey S Mogil; Anna Maria Aloisi
Journal:  Eur J Pain       Date:  2004-10       Impact factor: 3.931

2.  Menstrual variation in experimental pain: correlation with gonadal hormones.

Authors:  M Teepker; M Peters; H Vedder; K Schepelmann; S Lautenbacher
Journal:  Neuropsychobiology       Date:  2010-01-29       Impact factor: 2.328

3.  Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress.

Authors:  Y Takada; C Kato; S Kondo; R Korenaga; J Ando
Journal:  Biochem Biophys Res Commun       Date:  1997-11-26       Impact factor: 3.575

4.  Brain gray matter decrease in chronic pain is the consequence and not the cause of pain.

Authors:  Rea Rodriguez-Raecke; Andreas Niemeier; Kristin Ihle; Wolfgang Ruether; Arne May
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

5.  Endogenous opioids mediate left dorsolateral prefrontal cortex rTMS-induced analgesia.

Authors:  Joseph J Taylor; Jeffrey J Borckardt; Mark S George
Journal:  Pain       Date:  2012-03-22       Impact factor: 6.961

6.  Sex, pain, and opioids: interdependent influences of sex and pain modality on dynorphin-mediated antinociception in rats.

Authors:  Nai-Jiang Liu; Stephen Schnell; Martin W Wessendorf; Alan R Gintzler
Journal:  J Pharmacol Exp Ther       Date:  2012-12-10       Impact factor: 4.030

7.  Aromatase immunoreactivity in axon terminals of the vertebrate brain. An immunocytochemical study on quail, rat, monkey and human tissues.

Authors:  F Naftolin; T L Horvath; R L Jakab; C Leranth; N Harada; J Balthazart
Journal:  Neuroendocrinology       Date:  1996-02       Impact factor: 4.914

8.  Ablation of estrogen receptor alpha or beta eliminates sex differences in mechanical pain threshold in normal and inflamed mice.

Authors:  Lili Li; Xiaotang Fan; Margaret Warner; Xiao-Jun Xu; Jan-Ake Gustafsson; Zsuzsanna Wiesenfeld-Hallin
Journal:  Pain       Date:  2009-03-13       Impact factor: 6.961

9.  Spinal endomorphin 2 antinociception and the mechanisms that produce it are both sex- and stage of estrus cycle-dependent in rats.

Authors:  Nai-Jiang Liu; Alan R Gintzler
Journal:  J Pain       Date:  2013-09-29       Impact factor: 5.820

Review 10.  Sex, gender, and pain: a review of recent clinical and experimental findings.

Authors:  Roger B Fillingim; Christopher D King; Margarete C Ribeiro-Dasilva; Bridgett Rahim-Williams; Joseph L Riley
Journal:  J Pain       Date:  2009-05       Impact factor: 5.820

View more
  3 in total

1.  Estrogen metabolites increase nociceptor hyperactivity in a mouse model of uterine pain.

Authors:  Zili Xie; Jing Feng; Tao Cai; Ronald McCarthy; Mark D Eschbach; Yuhui Wang; Yonghui Zhao; Zhihua Yi; Kaikai Zang; Yi Yuan; Xueming Hu; Fengxian Li; Qin Liu; Aditi Das; Sarah K England; Hongzhen Hu
Journal:  JCI Insight       Date:  2022-05-23

2.  Our Life and Times….Alan R. Gintzler, Ph.D. (1947-2021) Analgesics, Endogenous Opioids and the Variable of Sex.

Authors:  Anne Z Murphy; Mark Stewart; Martin Wessendorf
Journal:  Front Pain Res (Lausanne)       Date:  2021-09-07

Review 3.  Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors.

Authors:  Mariacristina Mazzitelli; Peyton Presto; Nico Antenucci; Shakira Meltan; Volker Neugebauer
Journal:  Cells       Date:  2022-08-21       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.